SOLVAC SA-REG (SOLV.BR) Fundamental Analysis & Valuation

EBR:SOLV • BE0003545531

67.6 EUR
-1.8 (-2.59%)
Last: Mar 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This SOLV.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Overall SOLV gets a fundamental rating of 4 out of 10. We evaluated SOLV against 67 industry peers in the Chemicals industry. Both the profitability and the financial health of SOLV get a neutral evaluation. Nothing too spectacular is happening here. SOLV is valued correctly, but it does not seem to be growing. Finally SOLV also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. SOLV.BR Profitability Analysis

1.1 Basic Checks

  • In the past year SOLV was profitable.
  • SOLV had positive earnings in 4 of the past 5 years.
  • In multiple years SOLV reported negative operating cash flow during the last 5 years.
SOLV.BR Yearly Net Income VS EBIT VS OCF VS FCFSOLV.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.55%, SOLV is in the better half of the industry, outperforming 62.69% of the companies in the same industry.
  • With a Return On Equity value of 5.00%, SOLV perfoms like the industry average, outperforming 58.21% of the companies in the same industry.
  • With a Return On Invested Capital value of 3.65%, SOLV perfoms like the industry average, outperforming 53.73% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for SOLV is below the industry average of 6.88%.
  • The last Return On Invested Capital (3.65%) for SOLV is above the 3 year average (3.44%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.55%
ROE 5%
ROIC 3.65%
ROA(3y)4.3%
ROA(5y)2.1%
ROE(3y)4.67%
ROE(5y)2.26%
ROIC(3y)3.44%
ROIC(5y)N/A
SOLV.BR Yearly ROA, ROE, ROICSOLV.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • The Profit Margin of SOLV (95.09%) is better than 98.51% of its industry peers.
  • SOLV's Profit Margin has improved in the last couple of years.
  • SOLV's Operating Margin of 97.93% is amongst the best of the industry. SOLV outperforms 100.00% of its industry peers.
  • SOLV's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 97.93%
PM (TTM) 95.09%
GM N/A
OM growth 3Y-0.21%
OM growth 5Y2.47%
PM growth 3Y-1.44%
PM growth 5Y1.71%
GM growth 3YN/A
GM growth 5YN/A
SOLV.BR Yearly Profit, Operating, Gross MarginsSOLV.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 100 200 300 400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. SOLV.BR Health Analysis

2.1 Basic Checks

  • SOLV has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, SOLV has about the same amount of shares outstanding.
  • The debt/assets ratio for SOLV has been reduced compared to a year ago.
SOLV.BR Yearly Shares OutstandingSOLV.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SOLV.BR Yearly Total Debt VS Total AssetsSOLV.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • SOLV has an Altman-Z score of 4.54. This indicates that SOLV is financially healthy and has little risk of bankruptcy at the moment.
  • SOLV's Altman-Z score of 4.54 is amongst the best of the industry. SOLV outperforms 89.55% of its industry peers.
  • SOLV has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.06, SOLV belongs to the top of the industry, outperforming 89.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 4.54
ROIC/WACCN/A
WACCN/A
SOLV.BR Yearly LT Debt VS Equity VS FCFSOLV.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 0.69 indicates that SOLV may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.69, SOLV is doing worse than 91.04% of the companies in the same industry.
  • SOLV has a Quick Ratio of 0.69. This is a bad value and indicates that SOLV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SOLV has a worse Quick ratio (0.69) than 83.58% of its industry peers.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.69
SOLV.BR Yearly Current Assets VS Current LiabilitesSOLV.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. SOLV.BR Growth Analysis

3.1 Past

  • SOLV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.57%.
  • SOLV shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 26.70% yearly.
  • The Revenue for SOLV has decreased by -38.28% in the past year. This is quite bad
  • SOLV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.62% yearly.
EPS 1Y (TTM)-38.57%
EPS 3Y-29.04%
EPS 5Y26.7%
EPS Q2Q%28%
Revenue 1Y (TTM)-38.28%
Revenue growth 3Y-28%
Revenue growth 5Y24.62%
Sales Q2Q%26.75%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y6.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SOLV.BR Yearly Revenue VS EstimatesSOLV.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B
SOLV.BR Yearly EPS VS EstimatesSOLV.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 5 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. SOLV.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 11.48, the valuation of SOLV can be described as reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of SOLV indicates a rather cheap valuation: SOLV is cheaper than 88.06% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of SOLV to the average of the S&P500 Index (26.29), we can say SOLV is valued rather cheaply.
  • The Price/Forward Earnings ratio is 4.65, which indicates a rather cheap valuation of SOLV.
  • Based on the Price/Forward Earnings ratio, SOLV is valued cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.60. SOLV is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.48
Fwd PE 4.65
SOLV.BR Price Earnings VS Forward Price EarningsSOLV.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SOLV.BR Per share dataSOLV.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.72
PEG (5Y)0.43
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. SOLV.BR Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.86%, SOLV is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.29, SOLV pays a better dividend. On top of this SOLV pays more dividend than 92.54% of the companies listed in the same industry.
  • SOLV's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 5.86%

5.2 History

  • The dividend of SOLV has a limited annual growth rate of 1.34%.
Dividend Growth(5Y)1.34%
Div Incr Years0
Div Non Decr Years0
SOLV.BR Yearly Dividends per shareSOLV.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

  • SOLV's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
SOLV.BR Yearly Income VS Free CF VS DividendSOLV.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

More info and screens

Find the best dividend stocksShow peers with best dividend

SOLV.BR Fundamentals: All Metrics, Ratios and Statistics

SOLVAC SA-REG

EBR:SOLV (3/6/2026, 7:00:00 PM)

67.6

-1.8 (-2.59%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-06
Earnings (Next)07-30
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.24%
Ins Owner ChangeN/A
Market Cap1.45B
Revenue(TTM)132.44M
Net Income(TTM)125.93M
Analysts44
Price Target108.27 (60.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.86%
Yearly Dividend5.8
Dividend Growth(5Y)1.34%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.48
Fwd PE 4.65
P/S 10.91
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.57
EV/EBITDA N/A
EPS(TTM)5.89
EY8.71%
EPS(NY)14.52
Fwd EY21.49%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.19
BVpS117.7
TBVpS117.7
PEG (NY)1.72
PEG (5Y)0.43
Graham Number124.89
Profitability
Industry RankSector Rank
ROA 4.55%
ROE 5%
ROCE 4.86%
ROIC 3.65%
ROICexc 3.74%
ROICexgc 3.74%
OM 97.93%
PM (TTM) 95.09%
GM N/A
FCFM N/A
ROA(3y)4.3%
ROA(5y)2.1%
ROE(3y)4.67%
ROE(5y)2.26%
ROIC(3y)3.44%
ROIC(5y)N/A
ROICexc(3y)3.44%
ROICexc(5y)N/A
ROICexgc(3y)3.61%
ROICexgc(5y)N/A
ROCE(3y)4.58%
ROCE(5y)N/A
ROICexgc growth 3Y-27.07%
ROICexgc growth 5Y31.12%
ROICexc growth 3Y-24.14%
ROICexc growth 5Y34%
OM growth 3Y-0.21%
OM growth 5Y2.47%
PM growth 3Y-1.44%
PM growth 5Y1.71%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.69
Altman-Z 4.54
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.57%
EPS 3Y-29.04%
EPS 5Y26.7%
EPS Q2Q%28%
EPS Next Y6.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-38.28%
Revenue growth 3Y-28%
Revenue growth 5Y24.62%
Sales Q2Q%26.75%
Revenue Next Year3.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.25%
EBIT growth 3Y-28.15%
EBIT growth 5Y27.7%
EBIT Next Year44.79%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y35.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.44%
OCF growth 3YN/A
OCF growth 5YN/A

SOLVAC SA-REG / SOLV.BR FAQ

Can you provide the ChartMill fundamental rating for SOLVAC SA-REG?

ChartMill assigns a fundamental rating of 4 / 10 to SOLV.BR.


What is the valuation status of SOLVAC SA-REG (SOLV.BR) stock?

ChartMill assigns a valuation rating of 5 / 10 to SOLVAC SA-REG (SOLV.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for SOLVAC SA-REG?

SOLVAC SA-REG (SOLV.BR) has a profitability rating of 5 / 10.


How financially healthy is SOLVAC SA-REG?

The financial health rating of SOLVAC SA-REG (SOLV.BR) is 4 / 10.